Back to Agenda
FDA Guidance Update
Session Chair(s)
Michele Hardy
Vice President, Regulatory Advertising and Promotion Policy
GlaxoSmithKline, United States
The panel will discuss guidances that significantly impacts the promotion and advertising of medical products. The panel will describe the importance of the guidances to the promotional practices and materials for medical products. The panel will also provide an update on future planning for FDA guidance development.
Speaker(s)
Panelist
Bryant Godfrey, JD, MHA
Foley Hoag, United States
Partner, Co-Chair, FDA Practice
Panelist
Marci C. Kiester, PharmD
FDA, United States
Deputy Director, Office of Prescription Drug Promotion, OMP, CDER
Panelist
Cynthia Ng, JD
FDA, United States
Regulatory Counsel
Have an account?